News

The FDA has approved the SAPIEN 3 platform, a TAVR therapy, for patients with severe aortic stenosis without symptoms.
MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...
Edwards Lifesciences Corp.’s Sapien 3 platform has been approved for a new indication. The Food and Drug Administration ...
After a trial shows early intervention prevents hospitalization, the US Food and Drug Administration approves transcatheter ...
delaying vital treatment." “4D flow MRI is an advanced heart imaging method that allows us to look at blood flow in three ...
Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...
Scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ...
Before your blood gets pumped out of your heart to circulate through the body, it must pass through the aortic valve. If the aortic valve becomes narrowed or hardened, the condition known as ...
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement ...
University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.
FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis By Lori Solomon HealthDay ReporterMONDAY, May 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...